Atlas Trials

High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

Clinical trial NCT00002763 · UNKNOWN

Trial details

NCT number
NCT00002763
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Melanoma (Skin)
Start date
1996-04-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.